Gene Therapy-based Drug Market Report

Global and Regional Gene Therapy-based Drug Market Details Research Report 2021-2026

  • POSTDATE：Jul 05, 2021
  • PAGES：175
  • REPORT CODE：GMM758390
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Global Gene Therapy-based Drug Market Report provides evaluation of the market development from historical studies. This report further provides forecasts by performing comprehensive market analysis.  It covers thorough market analysis for the forecasted period 2021-2026. Moreover, this market study focuses on market classification into different segments along with thorough analysis of the competitors, key players and their profiles. The market size is calculated on the basis of revenue generated and volume.  Knowing dynamics of the market plays an important role and this report sheds light on dynamics like drivers and restraints.

    Such comprehensive Gene Therapy-based Drug market report further covers factors that influence market along with potent developing factors for various End-users, Types and Regions to outline the most capturing development trends of the Hydraulic Work Supports Industry. In addition, it focuses on some prominent investment sectors in regions such as Latin America, Europe, Asia Pacific, Africa and Middle East. This unique market report presents precious opinion of strategic adjustments for new key entrant as well present groups. In this research analysis, market capacity and consumption potential of prominent players are mentioned.

    In 2020, COVID-19 has had a certain impact on the global economy, so the report considers the impact of COVID-19 on the Global Gene Therapy-based Drug market.

    By Player:

    • Novartis

    • Human Stem Cells Institute

    • Alnylam Pharmaceuticals

    • Sunway Biotech

    • Akcea Therapeutics

    • Orchard Therapeutics

    • Amgen

    • bluebird bio

    • AnGes

    • Sarepta Therapeutics

    • SIBIONO

    • Gilead Sciences

    • Spark Therapeutics

    • Biogen

    By Type:

    • Viral Gene Delivery System

    • Non-viral Gene Delivery System

    By End-User:

    • Neurological Diseases

    • Cancer

    • Other

    By Geography:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • United Kingdom

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Turkey

    • Poland

    • Sweden

    • Belgium

    • Austria

    • Others

    Asia

    • China

    • Japan

    • India

    • South Korea

    • Indonesia

    • Thailand

    • Malaysia

    • Singapore

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Argentina

    • Colombia

    • Chile

    • Others

    Middle East

    • United Arab Emirates (UAE)

    • Saudi Arabia

    • Others

    Africa

    • Nigeria

    • Egypt

    • South Africa

    • Others

    Oceania

    • Australia

    • New Zealand

    • Others


    Major Reasons to Buy this Report

    This market report is the perfect presentation of the qualitative and quantitative analysis of the market according to categorization considering economic and non-economic factors.

    • It also provides provision of market value (USD Million) data for every segment and sub-segment.

    • This report further focuses on prominent regions and segmentation of the market, which is anticipated to record the rapid growth and dominate the market.

    • Market analysis is done on the basis of major regions covering consumption of the product in particular region and factors affecting the market growth in every region.

    • This market report further sheds light on competitive landscape, which indicates the place of the prominent key players in the market. It also covers a few crucial market strategies followed by the major players of the market such as partnerships, new service launches, business expansions and acquisitions of the companies profiled during last five years.

    • This market study sheds light on a wide range of company profiles, which contain company insights, SWOT analysis for the prominent industry players, company overview and product benchmarking.

    • The present and future market outlook of the industry is also mentioned in this unique market report along with recent development such as drivers, opportunities, challenges and market restricting factors of developed and rising regions.  

    • This market report is the unique depiction of porter’s five forces analysis, which is performed thorough analysis of the market perspectives.  Insights into market scenario is provided through value chain

    •  It further focuses on growth opportunities of upcoming years and depicts market scenario along with market dynamics.

    • This market report also provides six month post-sales analyst support.


    Customization of the Report

    Please feel free to contact our sales team in case of any Query or Customization Requirements. Our expert team will give you right solutions for your query.

  • TABLE OF CONTENT

    1 Gene Therapy-based Drug Market Overview

    • 1.1 Product Definition and Study Scope

      • 1.1.1 Study Scope by Types

      • 1.1.2 Study Scope by Application

    • 1.2 Market Overview and Trends

      • 1.2.1 Global Gene Therapy-based Drug Market Size and Growth Rate from 2016 to 2026

      • 1.2.2 Market Overview (Current Market Status)

      • 1.2.3 Qualitative Analysis of Market Trends

    • 1.3 Business Environment Analysis Tools

      • 1.3.1 PESTEL Analysis

      • 1.3.2 Porter's Five Forces Analysis

      • 1.3.3 Major Deals & Strategic Alliances Analysis

    2 Major Players Market Position

    • 2.1 Global Gene Therapy-based Drug Production Capacity and Market Share by Manufacturers (2016-2021)

    • 2.2 Global Gene Therapy-based Drug Market Revenue and Market Share by Manufacturers (2016-2021)

    • 2.3 Global Gene Therapy-based Drug Market Revenue and Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • 2.4 Manufacturers Gene Therapy-based Drug Plant Distribution and Sales Country

    3 Key Competitor and Financial Performance

    • 3.1 Novartis

      • 3.1.1 Novartis - Company Business Overview

      • 3.1.2 Novartis - Company Financial Performance

      • 3.1.3 Novartis - Company Financial Performance of Gene Therapy-based Drug

      • 3.1.4 Gene Therapy-based Drug Product Benchmarking

      • 3.1.5 Strategic Initiatives

    • 3.2 Human Stem Cells Institute

      • 3.2.1 Human Stem Cells Institute - Company Business Overview

      • 3.2.2 Human Stem Cells Institute - Company Financial Performance

      • 3.2.3 Human Stem Cells Institute - Company Financial Performance of Gene Therapy-based Drug

      • 3.2.4 Gene Therapy-based Drug Product Benchmarking

      • 3.2.5 Strategic Initiatives

    • 3.3 Alnylam Pharmaceuticals

      • 3.3.1 Alnylam Pharmaceuticals - Company Business Overview

      • 3.3.2 Alnylam Pharmaceuticals - Company Financial Performance

      • 3.3.3 Alnylam Pharmaceuticals - Company Financial Performance of Gene Therapy-based Drug

      • 3.3.4 Gene Therapy-based Drug Product Benchmarking

      • 3.3.5 Strategic Initiatives

    • 3.4 Sunway Biotech

      • 3.4.1 Sunway Biotech - Company Business Overview

      • 3.4.2 Sunway Biotech - Company Financial Performance

      • 3.4.3 Sunway Biotech - Company Financial Performance of Gene Therapy-based Drug

      • 3.4.4 Gene Therapy-based Drug Product Benchmarking

      • 3.4.5 Strategic Initiatives

    • 3.5 Akcea Therapeutics

      • 3.5.1 Akcea Therapeutics - Company Business Overview

      • 3.5.2 Akcea Therapeutics - Company Financial Performance

      • 3.5.3 Akcea Therapeutics - Company Financial Performance of Gene Therapy-based Drug

      • 3.5.4 Gene Therapy-based Drug Product Benchmarking

      • 3.5.5 Strategic Initiatives

    • 3.6 Orchard Therapeutics

      • 3.6.1 Orchard Therapeutics - Company Business Overview

      • 3.6.2 Orchard Therapeutics - Company Financial Performance

      • 3.6.3 Orchard Therapeutics - Company Financial Performance of Gene Therapy-based Drug

      • 3.6.4 Gene Therapy-based Drug Product Benchmarking

      • 3.6.5 Strategic Initiatives

    • 3.7 Amgen

      • 3.7.1 Amgen - Company Business Overview

      • 3.7.2 Amgen - Company Financial Performance

      • 3.7.3 Amgen - Company Financial Performance of Gene Therapy-based Drug

      • 3.7.4 Gene Therapy-based Drug Product Benchmarking

      • 3.7.5 Strategic Initiatives

    • 3.8 bluebird bio

      • 3.8.1 bluebird bio - Company Business Overview

      • 3.8.2 bluebird bio - Company Financial Performance

      • 3.8.3 bluebird bio - Company Financial Performance of Gene Therapy-based Drug

      • 3.8.4 Gene Therapy-based Drug Product Benchmarking

      • 3.8.5 Strategic Initiatives

    • 3.9 AnGes

      • 3.9.1 AnGes - Company Business Overview

      • 3.9.2 AnGes - Company Financial Performance

      • 3.9.3 AnGes - Company Financial Performance of Gene Therapy-based Drug

      • 3.9.4 Gene Therapy-based Drug Product Benchmarking

      • 3.9.5 Strategic Initiatives

    • 3.10 Sarepta Therapeutics

      • 3.10.1 Sarepta Therapeutics - Company Business Overview

      • 3.10.2 Sarepta Therapeutics - Company Financial Performance

      • 3.10.3 Sarepta Therapeutics - Company Financial Performance of Gene Therapy-based Drug

      • 3.10.4 Gene Therapy-based Drug Product Benchmarking

      • 3.10.5 Strategic Initiatives

    • 3.11 SIBIONO

      • 3.11.1 SIBIONO - Company Business Overview

      • 3.11.2 SIBIONO - Company Financial Performance

      • 3.11.3 SIBIONO - Company Financial Performance of Gene Therapy-based Drug

      • 3.11.4 Gene Therapy-based Drug Product Benchmarking

      • 3.11.5 Strategic Initiatives

    • 3.12 Gilead Sciences

      • 3.12.1 Gilead Sciences - Company Business Overview

      • 3.12.2 Gilead Sciences - Company Financial Performance

      • 3.12.3 Gilead Sciences - Company Financial Performance of Gene Therapy-based Drug

      • 3.12.4 Gene Therapy-based Drug Product Benchmarking

      • 3.12.5 Strategic Initiatives

    • 3.13 Spark Therapeutics

      • 3.13.1 Spark Therapeutics - Company Business Overview

      • 3.13.2 Spark Therapeutics - Company Financial Performance

      • 3.13.3 Spark Therapeutics - Company Financial Performance of Gene Therapy-based Drug

      • 3.13.4 Gene Therapy-based Drug Product Benchmarking

      • 3.13.5 Strategic Initiatives

    • 3.14 Biogen

      • 3.14.1 Biogen - Company Business Overview

      • 3.14.2 Biogen - Company Financial Performance

      • 3.14.3 Biogen - Company Financial Performance of Gene Therapy-based Drug

      • 3.14.4 Gene Therapy-based Drug Product Benchmarking

      • 3.14.5 Strategic Initiatives

    4 Global Gene Therapy-based Drug Market Segment Analysis (Types Level)

    • 4.1 Purchasing Strategy based on Purchasing Positioning Model

    • 4.2 Global Gene Therapy-based Drug Market Revenue and Market Share by Types (Historical)

      • 4.2.1 Global Revenue and Growth Rate of Viral Gene Delivery System 2016-2021

      • 4.2.2 Global Revenue and Growth Rate of Non-viral Gene Delivery System 2016-2021

    • 4.3 Global Gene Therapy-based Drug Market Sales and Market Share by Types (Historical)

      • 4.3.1 Global Sales and Growth Rate of Viral Gene Delivery System 2016-2021

      • 4.3.2 Global Sales and Growth Rate of Non-viral Gene Delivery System 2016-2021

    • 4.4 Global Gene Therapy-based Drug Market Revenue and Market Share by Types (Forecast)

    • 4.5 Global Gene Therapy-based Drug Market Sales and Market Share by Types (Forecast)

    • 4.6 Global Gene Therapy-based Drug Market Price By Type from 2016 to 2026

    5 Global Gene Therapy-based Drug Market Segment Analysis (Application Level)

    • 5.1 Downstream Industry Demand Analysis of Gene Therapy-based Drug

    • 5.2 Global Gene Therapy-based Drug Market Revenue and Market Share by Application (Historical)

      • 5.2.1 Global Revenue and Growth Rate of Neurological Diseases 2016-2021

      • 5.2.2 Global Revenue and Growth Rate of Cancer 2016-2021

      • 5.2.3 Global Revenue and Growth Rate of Other 2016-2021

    • 5.3 Global Gene Therapy-based Drug Market Sales and Market Share by Application (Historical)

      • 5.3.1 Global Sales and Growth Rate of Neurological Diseases 2016-2021

      • 5.3.2 Global Sales and Growth Rate of Cancer 2016-2021

      • 5.3.3 Global Sales and Growth Rate of Other 2016-2021

    • 5.4 Global Gene Therapy-based Drug Market Revenue and Market Share by Application (Forecast)

    • 5.5 Global Gene Therapy-based Drug Market Sales and Market Share by Application (Forecast)

    6 Global Gene Therapy-based Drug Market Segment Analysis (Geography Level)

    • 6.1 Global Gene Therapy-based Drug Market Revenue and Market Share by Geography (Historical)

    • 6.2 Global Gene Therapy-based Drug Market Sales and Market Share by Geography (Historical)

    • 6.3 Global Gene Therapy-based Drug Market Revenue and Market Share by Geography (Forecast)

    • 6.4 Global Gene Therapy-based Drug Market Sales and Market Share by Geography (Forecast)

    • 6.5 Top Sales Country Advantage Analysis

    • 6.6 Top 5 Export Countries in Gene Therapy-based Drug Market from 2016 to 2020

    • 6.7 Top 5 Import Countries in Gene Therapy-based Drug Market from 2016 to 2020

    7. North America Gene Therapy-based Drug Market Segment Analysis and Investment Attractiveness

    • 7.1 North America Gene Therapy-based Drug Market Segment by Countries

      • 7.1.1 North America Gene Therapy-based Drug Market Revenue Segment by Countries

      • 7.1.2 North America Gene Therapy-based Drug Market Sales Segment by Countries

      • 7.1.3 USA

      • 7.1.4 Canada

      • 7.1.5 Mexico

    • 7.2 North America Gene Therapy-based Drug Market Segment (Product Type Level)

    • 7.3 North America Gene Therapy-based Drug Market Segment (Application/Industry Level)

    • 7.4 Key Country Economy in North America

    • 7.5 Analysis of Investment Attractiveness of Major Countries

    8 Europe Gene Therapy-based Drug Market Segment Analysis and Investment Attractiveness

    • 8.1 Europe Gene Therapy-based Drug Market Segment by Countries

      • 8.1.1 Europe Gene Therapy-based Drug Market Revenue Segment by Countries

      • 8.1.2 Europe Gene Therapy-based Drug Market Sales Segment by Countries

      • 8.1.3 Germany

      • 8.1.4 United Kingdom

      • 8.1.5 France

      • 8.1.6 Italy

      • 8.1.7 Russia

      • 8.1.8 Spain

      • 8.1.9 Netherlands

      • 8.1.10 Switzerland

      • 8.1.11 Turkey

      • 8.1.12 Poland

      • 8.1.13 Sweden

      • 8.1.14 Belgium

      • 8.1.15 Austria

      • 8.1.16 Others

    • 8.2 Europe Gene Therapy-based Drug Market Segment (Product Type Level)

    • 8.3 Europe Gene Therapy-based Drug Market Segment (Application/Industry Level)

    • 8.4 Key Country Economy in Europe

    • 8.5 Analysis of Investment Attractiveness of Major Countries

    9 Asia Gene Therapy-based Drug Market Segment Analysis and Investment Attractiveness

    • 9.1 Asia Gene Therapy-based Drug Market Segment by Countries

      • 9.1.1 Asia Gene Therapy-based Drug Market Revenue Segment by Countries

      • 9.1.2 Asia Gene Therapy-based Drug Market Sales Segment by Countries

      • 9.1.3 China

      • 9.1.4 Japan

      • 9.1.5 India

      • 9.1.6 South Korea

      • 9.1.7 Malaysia

      • 9.1.8 Vietnam

      • 9.1.9 Philippines

      • 9.1.10 Singapore

      • 9.1.11 Thailand

      • 9.1.12 Others

    • 9.2 Asia Gene Therapy-based Drug Market Segment (Product Type Level)

    • 9.3 Asia Gene Therapy-based Drug Market Segment (Application/Industry Level)

    • 9.4 Key Country Economy in Asia Pacific

    • 9.5 Analysis of Investment Attractiveness of Major Countries

    10 South America Gene Therapy-based Drug Market Segment Analysis and Investment Attractiveness

    • 10.1 South America Gene Therapy-based Drug Market Segment by Countries

      • 10.1.1 South America Gene Therapy-based Drug Market Revenue Segment by Countries

      • 10.1.2 South America Gene Therapy-based Drug Market Sales Segment by Countries

      • 10.1.3 Brazil

      • 10.1.4 Argentina

      • 10.1.5 Colombia

      • 10.1.6 Chile

      • 10.1.7 Others

    • 10.2 South America Gene Therapy-based Drug Market Segment (Product Type Level)

    • 10.3 South America Gene Therapy-based Drug Market Segment (Application/Industry Level)

    • 10.4 Key Country Economy in Asia Pacific

    • 10.5 Analysis of Investment Attractiveness of Major Countries

    11 Middle East Gene Therapy-based Drug Market Segment Analysis and Investment Attractiveness

    • 11.1 Middle East Gene Therapy-based Drug Market Segment by Countries

      • 11.1.1 Middle East Gene Therapy-based Drug Market Revenue Segment by Countries

      • 11.1.2 Middle East Gene Therapy-based Drug Market Sales Segment by Countries

      • 11.1.3 United Arab Emirates (UAE)

      • 11.1.4 Saudi Arabia

      • 11.1.5 Others

    • 11.2 Middle East Gene Therapy-based Drug Market Segment (Product Type Level)

    • 11.3 Middle East Gene Therapy-based Drug Market Segment (Application/Industry Level)

    • 11.4 Key Country Economy in Middle East

    • 11.5 Analysis of Investment Attractiveness of Major Countries

    12 Africa Gene Therapy-based Drug Market Segment Analysis and Investment Attractiveness

    • 12.1 Africa Gene Therapy-based Drug Market Segment by Countries

      • 12.1.1 Africa Gene Therapy-based Drug Market Revenue Segment by Countries

      • 12.1.2 Africa Gene Therapy-based Drug Market Sales Segment by Countries

      • 12.1.3 Nigeria

      • 12.1.4 Egypt

      • 12.1.5 South Africa

      • 12.1.6 Others

    • 12.2 Africa Gene Therapy-based Drug Market Segment (Product Type Level)

    • 12.3 Africa Gene Therapy-based Drug Market Segment (Application/Industry Level)

    • 12.4 Key Country Economy in Africa

    • 12.5 Analysis of Investment Attractiveness of Major Countries

    13 Oceania Gene Therapy-based Drug Market Segment Analysis and Investment Attractiveness

    • 13.1 Oceania Gene Therapy-based Drug Market Segment by Countries

      • 13.1.1 Oceania Gene Therapy-based Drug Market Revenue Segment by Countries

      • 13.1.2 Oceania Gene Therapy-based Drug Market Sales Segment by Countries

      • 13.1.3 Australia

      • 13.1.4 New Zealand

      • 13.1.5 Others

    • 13.2 Oceania Gene Therapy-based Drug Market Segment (Product Type Level)

    • 13.3 Oceania Gene Therapy-based Drug Market Segment (Application/Industry Level)

    • 13.4 Key Country Economy in Oceania

    • 13.5 Analysis of Investment Attractiveness of Major Countries

    14 Supply Chain Analysis

    • 14.1 Upstream Market Analysis

      • 14.1.1 Key Raw Materials Production Base and Market Concentration Rate

      • 14.1.2 Key Raw Materials Price Trend

    • 14.2 Gene Therapy-based Drug Production Analysis

      • 14.2.1 Manufacturing Cost Structure of Gene Therapy-based Drug

      • 14.2.2 Manufacturing Process Analysis of Gene Therapy-based Drug

      • 14.2.3 Source of Technology

      • 14.2.4 Competitive Landscape

    • 14.3 Downstream Market Analysis

      • 14.3.1 Customer Positioning Analysis

      • 14.3.2 Major Downstream Buyers of Gene Therapy-based Drug Analysis

    15 Market Influences Factors Analysis

    • 15.1 Changes from the Related Industries

    • 15.2 Substitutes Threat

    • 15.3 Customer Preference Change

    • 15.4 Upstream and Downstream Fluctuation

    • 15.5 COVID-19 Impact

      • 15.5.1 COVID-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

      • 15.5.2 Gene Therapy-based Drug Industry Market Status, Pre-COVID-19

      • 15.5.3 Gene Therapy-based Drug Industry Market Status, Post-COVID-19

      • 15.5.4 Impact of COVID-19 on Supply Chain

    • 15.6 Post-COVID-19 Gene Therapy-based Drug Industry Opportunity

    16 Key Research Findings


    The List of Tables and Figures

    • Figure Gene Therapy-based Drug Product Picture

    • Table Gene Therapy-based Drug Product Definition

    • Table Study Scope by Types

    • Figure Global Gene Therapy-based Drug Market Value by Type (2016 - 2026)

    • Table Study Scope by Application

    • Figure Global Gene Therapy-based Drug Market Value by Application (2016 - 2026)

    • Figure Global Gene Therapy-based Drug Market Size and Growth Rate from 2016 to 2026

    • Table Global Gene Therapy-based Drug Production Capacity by Manufacturers (2016-2021)

    • Table Global Gene Therapy-based Drug Production Capacity Market Share by Manufacturers (2016-2021)

    • Table Global Gene Therapy-based Drug Revenue by Manufacturers (2016-2021)

    • Table Global Gene Therapy-based Drug Revenue Market Share by Manufacturers (2016-2021)

    • Table Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

    • Table Manufacturers Gene Therapy-based Drug Plant Distribution and Sales Country

    • Table Novartis - Company Business Overview

    • Figure Novartis Total Revenue from 2018 to 2020

    • Table Novartis Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Novartis Sales and Growth Rate Analysis of Gene Therapy-based Drug

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Gene Therapy-based Drug Product Benchmarking

    • Table Human Stem Cells Institute - Company Business Overview

    • Figure Human Stem Cells Institute Total Revenue from 2018 to 2020

    • Table Human Stem Cells Institute Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Human Stem Cells Institute Sales and Growth Rate Analysis of Gene Therapy-based Drug

    • Figure Revenue and Market Share Analysis of Human Stem Cells Institute

    • Table Gene Therapy-based Drug Product Benchmarking

    • Table Alnylam Pharmaceuticals - Company Business Overview

    • Figure Alnylam Pharmaceuticals Total Revenue from 2018 to 2020

    • Table Alnylam Pharmaceuticals Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Alnylam Pharmaceuticals Sales and Growth Rate Analysis of Gene Therapy-based Drug

    • Figure Revenue and Market Share Analysis of Alnylam Pharmaceuticals

    • Table Gene Therapy-based Drug Product Benchmarking

    • Table Sunway Biotech - Company Business Overview

    • Figure Sunway Biotech Total Revenue from 2018 to 2020

    • Table Sunway Biotech Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Sunway Biotech Sales and Growth Rate Analysis of Gene Therapy-based Drug

    • Figure Revenue and Market Share Analysis of Sunway Biotech

    • Table Gene Therapy-based Drug Product Benchmarking

    • Table Akcea Therapeutics - Company Business Overview

    • Figure Akcea Therapeutics Total Revenue from 2018 to 2020

    • Table Akcea Therapeutics Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Akcea Therapeutics Sales and Growth Rate Analysis of Gene Therapy-based Drug

    • Figure Revenue and Market Share Analysis of Akcea Therapeutics

    • Table Gene Therapy-based Drug Product Benchmarking

    • Table Orchard Therapeutics - Company Business Overview

    • Figure Orchard Therapeutics Total Revenue from 2018 to 2020

    • Table Orchard Therapeutics Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Orchard Therapeutics Sales and Growth Rate Analysis of Gene Therapy-based Drug

    • Figure Revenue and Market Share Analysis of Orchard Therapeutics

    • Table Gene Therapy-based Drug Product Benchmarking

    • Table Amgen - Company Business Overview

    • Figure Amgen Total Revenue from 2018 to 2020

    • Table Amgen Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Amgen Sales and Growth Rate Analysis of Gene Therapy-based Drug

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Gene Therapy-based Drug Product Benchmarking

    • Table bluebird bio - Company Business Overview

    • Figure bluebird bio Total Revenue from 2018 to 2020

    • Table bluebird bio Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure bluebird bio Sales and Growth Rate Analysis of Gene Therapy-based Drug

    • Figure Revenue and Market Share Analysis of bluebird bio

    • Table Gene Therapy-based Drug Product Benchmarking

    • Table AnGes - Company Business Overview

    • Figure AnGes Total Revenue from 2018 to 2020

    • Table AnGes Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure AnGes Sales and Growth Rate Analysis of Gene Therapy-based Drug

    • Figure Revenue and Market Share Analysis of AnGes

    • Table Gene Therapy-based Drug Product Benchmarking

    • Table Sarepta Therapeutics - Company Business Overview

    • Figure Sarepta Therapeutics Total Revenue from 2018 to 2020

    • Table Sarepta Therapeutics Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Sarepta Therapeutics Sales and Growth Rate Analysis of Gene Therapy-based Drug

    • Figure Revenue and Market Share Analysis of Sarepta Therapeutics

    • Table Gene Therapy-based Drug Product Benchmarking

    • Table SIBIONO - Company Business Overview

    • Figure SIBIONO Total Revenue from 2018 to 2020

    • Table SIBIONO Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure SIBIONO Sales and Growth Rate Analysis of Gene Therapy-based Drug

    • Figure Revenue and Market Share Analysis of SIBIONO

    • Table Gene Therapy-based Drug Product Benchmarking

    • Table Gilead Sciences - Company Business Overview

    • Figure Gilead Sciences Total Revenue from 2018 to 2020

    • Table Gilead Sciences Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Gilead Sciences Sales and Growth Rate Analysis of Gene Therapy-based Drug

    • Figure Revenue and Market Share Analysis of Gilead Sciences

    • Table Gene Therapy-based Drug Product Benchmarking

    • Table Spark Therapeutics - Company Business Overview

    • Figure Spark Therapeutics Total Revenue from 2018 to 2020

    • Table Spark Therapeutics Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Spark Therapeutics Sales and Growth Rate Analysis of Gene Therapy-based Drug

    • Figure Revenue and Market Share Analysis of Spark Therapeutics

    • Table Gene Therapy-based Drug Product Benchmarking

    • Table Biogen - Company Business Overview

    • Figure Biogen Total Revenue from 2018 to 2020

    • Table Biogen Sales, Revenue, Average Price and Gross Margin Analysis

    • Figure Biogen Sales and Growth Rate Analysis of Gene Therapy-based Drug

    • Figure Revenue and Market Share Analysis of Biogen

    • Table Gene Therapy-based Drug Product Benchmarking

    • Table Purchasing Strategy based on Purchasing Positioning Model

    • Table Global Gene Therapy-based Drug Market Revenue by Types (Historical)

    • Table Global Gene Therapy-based Drug Market Revenue Market Share by Types (Historical)

    • Figure Global Revenue and Growth Rate of Viral Gene Delivery System 2016-2021

    • Figure Global Revenue and Growth Rate of Non-viral Gene Delivery System 2016-2021

    • Table Global Gene Therapy-based Drug Market Sales by Types (Historical)

    • Table Global Gene Therapy-based Drug Market Sales Market Share by Types (Historical)

    • Figure Global Sales and Growth Rate of Viral Gene Delivery System 2016-2021

    • Figure Global Sales and Growth Rate of Non-viral Gene Delivery System 2016-2021

    • Table Global Gene Therapy-based Drug Market Revenue by Types (Forecast)

    • Table Global Gene Therapy-based Drug Market Revenue Market Share by Types (Forecast)

    • Table Global Gene Therapy-based Drug Market Sales by Types (Forecast)

    • Table Global Gene Therapy-based Drug Market Sales Market Share by Types (Forecast)

    • Figure Global Gene Therapy-based Drug Market Price By Type from 2016 to 2026

    • Table Downstream Industry Demand Analysis for Gene Therapy-based Drug

    • Table Global Gene Therapy-based Drug Market Revenue by Application (Historical)

    • Table Global Gene Therapy-based Drug Market Revenue Market Share by Application (Historical)

    • Figure Global Revenue and Growth Rate of Neurological Diseases 2016-2021

    • Figure Global Revenue and Growth Rate of Cancer 2016-2021

    • Figure Global Revenue and Growth Rate of Other 2016-2021

    • Table Global Gene Therapy-based Drug Market Sales by Application (Historical)

    • Table Global Gene Therapy-based Drug Market Sales Market Share by Application (Historical)

    • Figure Global Sales and Growth Rate of Neurological Diseases 2016-2021

    • Figure Global Sales and Growth Rate of Cancer 2016-2021

    • Figure Global Sales and Growth Rate of Other 2016-2021

    • Table Global Gene Therapy-based Drug Market Revenue by Application (Forecast)

    • Table Global Gene Therapy-based Drug Market Revenue Market Share by Application (Forecast)

    • Table Global Gene Therapy-based Drug Market Sales by Application (Forecast)

    • Table Global Gene Therapy-based Drug Market Sales Market Share by Application (Forecast)

    • Table Global Gene Therapy-based Drug Market Revenue by Geography (Historical)

    • Table Global Gene Therapy-based Drug Market Revenue Market Share by Geography (Historical)

    • Figure Global Gene Therapy-based Drug Revenue Market Share by Geography in 2020

    • Table Global Gene Therapy-based Drug Market Sales by Geography (Historical)

    • Table Global Gene Therapy-based Drug Market Sales Market Share by Geography (Historical)

    • Figure Global Gene Therapy-based Drug Sales Market Share by Geography in 2020

    • Table Global Gene Therapy-based Drug Market Revenue by Geography (Forecast)

    • Table Global Gene Therapy-based Drug Market Revenue Market Share by Geography (Forecast)

    • Table Global Gene Therapy-based Drug Market Sales by Geography (Forecast)

    • Table Global Gene Therapy-based Drug Market Sales Market Share by Geography (Forecast)

    • Figure Top Sales Country Geographical Advantage Analysis

    • Table North America Gene Therapy-based Drug Revenue by Countries from 2016 to 2026

    • Table North America Gene Therapy-based Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure North America Gene Therapy-based Drug Revenue Market Share by Major Countries in 2020

    • Table North America Gene Therapy-based Drug Sales by Countries from 2016 to 2026

    • Table North America Gene Therapy-based Drug Sales Market Share by Countries from 2016 to 2026

    • Figure North America Gene Therapy-based Drug Sales Market Share by Major Countries in 2020

    • Figure USA Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure USA Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Canada Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Canada Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Mexico Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Mexico Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Table North America Gene Therapy-based Drug Sales by Types from 2016 to 2026

    • Table North America Gene Therapy-based Drug Sales Market Share by Types from 2016 to 2026

    • Table North America Gene Therapy-based Drug Value by Types from 2016 to 2026

    • Table North America Gene Therapy-based Drug Value Market Share by Types from 2016 to 2026

    • Table North America Gene Therapy-based Drug Sales by Application from 2016 to 2026

    • Table North America Gene Therapy-based Drug Sales Market Share by Application from 2016 to 2026

    • Table North America Gene Therapy-based Drug Value by Application from 2016 to 2026

    • Table North America Gene Therapy-based Drug Value Market Share by Application from 2016 to 2026

    • Table Europe Gene Therapy-based Drug Revenue by Countries from 2016 to 2026

    • Table Europe Gene Therapy-based Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure Europe Gene Therapy-based Drug Revenue Market Share by Major Countries in 2020

    • Table Europe Gene Therapy-based Drug Sales by Countries from 2016 to 2026

    • Table Europe Gene Therapy-based Drug Sales Market Share by Countries from 2016 to 2026

    • Figure Europe Gene Therapy-based Drug Sales Market Share by Major Countries in 2020

    • Figure Germany Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Germany Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure United Kingdom Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure United Kingdom Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure France Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure France Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Italy Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Italy Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Russia Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Russia Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Spain Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Spain Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Netherlands Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Netherlands Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Switzerland Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Switzerland Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Turkey Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Turkey Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Poland Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Poland Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Sweden Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Sweden Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Belgium Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Belgium Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Austria Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Austria Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Others Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Table Europe Gene Therapy-based Drug Sales by Types from 2016 to 2026

    • Table Europe Gene Therapy-based Drug Sales Market Share by Types from 2016 to 2026

    • Table Europe Gene Therapy-based Drug Value by Types from 2016 to 2026

    • Table Europe Gene Therapy-based Drug Value Market Share by Types from 2016 to 2026

    • Table Europe Gene Therapy-based Drug Sales by Application from 2016 to 2026

    • Table Europe Gene Therapy-based Drug Sales Market Share by Application from 2016 to 2026

    • Table Europe Gene Therapy-based Drug Value by Application from 2016 to 2026

    • Table Europe Gene Therapy-based Drug Value Market Share by Application from 2016 to 2026

    • Table Asia Gene Therapy-based Drug Revenue by Countries from 2016 to 2026

    • Table Asia Gene Therapy-based Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure Asia Gene Therapy-based Drug Revenue Market Share by Major Countries in 2020

    • Table Asia Gene Therapy-based Drug Sales by Countries from 2016 to 2026

    • Table Asia Gene Therapy-based Drug Sales Market Share by Countries from 2016 to 2026

    • Figure Asia Gene Therapy-based Drug Sales Market Share by Major Countries in 2020

    • Figure China Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure China Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Japan Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Japan Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure India Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure India Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure South Korea Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure South Korea Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Malaysia Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Malaysia Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Vietnam Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Vietnam Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Philippines Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Philippines Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Singapore Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Singapore Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Thailand Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Thailand Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Others Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Table Asia Gene Therapy-based Drug Sales by Types from 2016 to 2026

    • Table Asia Gene Therapy-based Drug Sales Market Share by Types from 2016 to 2026

    • Table Asia Gene Therapy-based Drug Value by Types from 2016 to 2026

    • Table Asia Gene Therapy-based Drug Value Market Share by Types from 2016 to 2026

    • Table Asia Gene Therapy-based Drug Sales by Application from 2016 to 2026

    • Table Asia Gene Therapy-based Drug Sales Market Share by Application from 2016 to 2026

    • Table Asia Gene Therapy-based Drug Value by Application from 2016 to 2026

    • Table Asia Gene Therapy-based Drug Value Market Share by Application from 2016 to 2026

    • Table South America Gene Therapy-based Drug Revenue by Countries from 2016 to 2026

    • Table South America Gene Therapy-based Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure South America Gene Therapy-based Drug Revenue Market Share by Major Countries in 2020

    • Table South America Gene Therapy-based Drug Sales by Countries from 2016 to 2026

    • Table South America Gene Therapy-based Drug Sales Market Share by Countries from 2016 to 2026

    • Figure South America Gene Therapy-based Drug Sales Market Share by Major Countries in 2020

    • Figure Brazil Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Brazil Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Argentina Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Argentina Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Colombia Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Colombia Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Chile Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Chile Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Others Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Table South America Gene Therapy-based Drug Sales by Types from 2016 to 2026

    • Table South America Gene Therapy-based Drug Sales Market Share by Types from 2016 to 2026

    • Table South America Gene Therapy-based Drug Value by Types from 2016 to 2026

    • Table South America Gene Therapy-based Drug Value Market Share by Types from 2016 to 2026

    • Table South America Gene Therapy-based Drug Sales by Application from 2016 to 2026

    • Table South America Gene Therapy-based Drug Sales Market Share by Application from 2016 to 2026

    • Table South America Gene Therapy-based Drug Value by Application from 2016 to 2026

    • Table South America Gene Therapy-based Drug Value Market Share by Application from 2016 to 2026

    • Table Middle East Gene Therapy-based Drug Revenue by Countries from 2016 to 2026

    • Table Middle East Gene Therapy-based Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure Middle East Gene Therapy-based Drug Revenue Market Share by Major Countries in 2020

    • Table Middle East Gene Therapy-based Drug Sales by Countries from 2016 to 2026

    • Table Middle East Gene Therapy-based Drug Sales Market Share by Countries from 2016 to 2026

    • Figure Middle East Gene Therapy-based Drug Sales Market Share by Major Countries in 2020

    • Figure United Arab Emirates (UAE) Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure United Arab Emirates (UAE) Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Saudi Arabia Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Others Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Table Middle East Gene Therapy-based Drug Sales by Types from 2016 to 2026

    • Table Middle East Gene Therapy-based Drug Sales Market Share by Types from 2016 to 2026

    • Table Middle East Gene Therapy-based Drug Value by Types from 2016 to 2026

    • Table Middle East Gene Therapy-based Drug Value Market Share by Types from 2016 to 2026

    • Table Middle East Gene Therapy-based Drug Sales by Application from 2016 to 2026

    • Table Middle East Gene Therapy-based Drug Sales Market Share by Application from 2016 to 2026

    • Table Middle East Gene Therapy-based Drug Value by Application from 2016 to 2026

    • Table Middle East Gene Therapy-based Drug Value Market Share by Application from 2016 to 2026

    • Table Africa Gene Therapy-based Drug Revenue by Countries from 2016 to 2026

    • Table Africa Gene Therapy-based Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure Africa Gene Therapy-based Drug Revenue Market Share by Major Countries in 2020

    • Table Africa Gene Therapy-based Drug Sales by Countries from 2016 to 2026

    • Table Africa Gene Therapy-based Drug Sales Market Share by Countries from 2016 to 2026

      • Figure Africa Gene Therapy-based Drug Sales Market Share by Major Countries in 2020

    • Figure Nigeria Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Nigeria Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Egypt Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Egypt Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure South Africa Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure South Africa Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Others Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Table Africa Gene Therapy-based Drug Sales by Types from 2016 to 2026

    • Table Africa Gene Therapy-based Drug Sales Market Share by Types from 2016 to 2026

    • Table Africa Gene Therapy-based Drug Value by Types from 2016 to 2026

    • Table Africa Gene Therapy-based Drug Value Market Share by Types from 2016 to 2026

    • Table Africa Gene Therapy-based Drug Sales by Application from 2016 to 2026

    • Table Africa Gene Therapy-based Drug Sales Market Share by Application from 2016 to 2026

    • Table Africa Gene Therapy-based Drug Value by Application from 2016 to 2026

    • Table Africa Gene Therapy-based Drug Value Market Share by Application from 2016 to 2026

    • Table Oceania Gene Therapy-based Drug Revenue by Countries from 2016 to 2026

    • Table Oceania Gene Therapy-based Drug Revenue Market Share by Countries from 2016 to 2026

    • Figure Oceania Gene Therapy-based Drug Revenue Market Share by Major Countries in 2020

    • Table Oceania Gene Therapy-based Drug Sales by Countries from 2016 to 2026

    • Table Oceania Gene Therapy-based Drug Sales Market Share by Countries from 2016 to 2026

    • Figure Oceania Gene Therapy-based Drug Sales Market Share by Major Countries in 2020

    • Figure Australia Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Australia Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure New Zealand Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure New Zealand Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Figure Others Gene Therapy-based Drug Market Value and Growth Rate from 2016 to 2026

    • Figure Others Gene Therapy-based Drug Market Volume and Growth Rate from 2016 to 2026

    • Table Oceania Gene Therapy-based Drug Sales by Types from 2016 to 2026

    • Table Oceania Gene Therapy-based Drug Sales Market Share by Types from 2016 to 2026

    • Table Oceania Gene Therapy-based Drug Value by Types from 2016 to 2026

    • Table Oceania Gene Therapy-based Drug Value Market Share by Types from 2016 to 2026

    • Table Oceania Gene Therapy-based Drug Sales by Application from 2016 to 2026

    • Table Oceania Gene Therapy-based Drug Sales Market Share by Application from 2016 to 2026

    • Table Oceania Gene Therapy-based Drug Value by Application from 2016 to 2026

    • Table Oceania Gene Therapy-based Drug Value Market Share by Application from 2016 to 2026

    • Table Production Base and Market Concentration Rate of Raw Material

    • Figure Key Raw Materials Price Trend

    • Figure Manufacturing Process Analysis of Gene Therapy-based Drug

    • Figure Top 10 Market Share in 2020

    • Table Major Downstream Buyers of Gene Therapy-based Drug with Contact Information


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US